PHP
ICAD

Parkman Healthcare Partners’s iCAD Inc ICAD Stock Holding History

Parkman Healthcare Partners’s Portfolio ICAD Stock Details ICAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-781,670
Closed -$1.61M – 91
2025
Q1 		$1.61M Buy
+781,670
New +$1.99M 0.19% 79
2022
Q1 		– Sell
-103,302
Closed -$744K – 86
2021
Q4 		$744K Sell
103,302
-21,698
-17% -$194K 0.16% 79
2021
Q3 		$1.34M Sell
125,000
-406,255
-76% -$5.29M 0.34% 62
2021
Q2 		$9.2M Sell
531,255
-116,876
-18% -$2.05M 2.01% 15
2021
Q1 		$13.8M Buy
648,131
+105,529
+19% +$1.78M 3.19% 7
2020
Q4 		$7.16M Sell
542,602
-39,150
-7% -$422K 1.84% 22
2020
Q3 		$5.13M Sell
581,752
-143,838
-20% -$1.42M 1.36% 33
2020
Q2 		$7.25M Hold
725,590
– – 2.04% 17
2020
Q1 		$5.33M Buy
725,590
+124,904
+21% +$1.22M 2.47% 11
2019
Q4 		$4.67M Buy
+600,686
New +$4.29M 1.35% 28

Other funds holding ICAD

OBAM
ODDO BHF Asset Management Paris, France $2.54B AUM 41.83% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
YCM
Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return
MC
Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return
OAC
OMERS Administration Corp Toronto, Ontario, Canada $15.6B AUM 24.73% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
TC
Trium Capital London, United Kingdom $163M AUM 45.8% 1-Year Est. Return
CIEC
Crédit Industriel et Commercial Paris France, France $1.55B AUM 42.08% 1-Year Est. Return

Parkman Healthcare Partners's ICAD Position: Q2 2025 in Review

Parkman Healthcare Partners sold out of iCAD Inc (ICAD) in Q2 2025, closing a stake of 781,670 shares — an estimated $1.61M sold.

Parkman Healthcare Partners first reported a position in ICAD in Q4 2019 and held it in 10 quarters. The position peaked at $13.8M in Q1 2021. 60 funds tracked by Wall St. Rank hold ICAD as of Q2 2025.

  • Parkman Healthcare Partners reported no remaining iCAD Inc position as of Q2 2025 after selling out during the quarter.
  • Parkman Healthcare Partners sold 781,670 iCAD Inc shares in Q2 2025, an estimated $1.61M.
  • Parkman Healthcare Partners first reported a position in iCAD Inc in Q4 2019 and held it in 10 quarters.
  • Parkman Healthcare Partners's iCAD Inc position peaked at $13.8M in Q1 2021.
  • 60 funds tracked by Wall St. Rank held iCAD Inc as of Q2 2025.

Based on Parkman Healthcare Partners's 13F filing for Q2 2025, filed 14 Aug 2025.